Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100023 Immunoassay and antibody selection methods using cell surface expressed libraries
05/29/2003US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity
05/29/2003US20030100016 Complement C3 precursor biopolymer markers predictive of Alzheimers disease
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent
05/29/2003US20030100005 CRBs as modifiers of branching morphogenesis and methods of use
05/29/2003US20030100003 Method for detection and identification of Anacardium species specific sequence from a sample
05/29/2003US20030100002 Methods for preventing or reducing multiple antibiotic resistance in bacteria
05/29/2003US20030099996 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cardiovascular, cell proliferative, inflammatory and skin disorders
05/29/2003US20030099995 Protein for use in the diagnosis and treatment of cell proliferative and inflammatory disorders
05/29/2003US20030099994 Novel FDRG protein and nucleic acid molecules and uses therefor
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099990 TALL-1 receptor molecules and uses thereof
05/29/2003US20030099988 Novel Human tumor suppressor
05/29/2003US20030099982 Regulation of human glur5 -like receptor
05/29/2003US20030099980 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, and inflammamtory diseases
05/29/2003US20030099978 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
05/29/2003US20030099976 Androgen receptor complex-associated protein
05/29/2003US20030099974 Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099969 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of apoptosis disorders
05/29/2003US20030099965 Nucleic acids encoding human CIDE-B protein and polymorphic markers thereof
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099955 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
05/29/2003US20030099947 Nucleotide sequences coding polypeptide for use in treatment mof inflammation, nervous system and autoimmune diseases
05/29/2003US20030099938 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
05/29/2003US20030099935 Core structure of GP41 from the HIV envelope glycoprotein
05/29/2003US20030099934 Envelope protein for use in the treatment and prevention of viral diseases
05/29/2003US20030099932 Expression vector for as gene transfer and diagnostic tool in genetic engineering
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099714 Co-lyophilizing one or more peptides or peptide analogues, which are able to adopt an amphipathic conformation and one or more lipids in a solvent system to form a peptide/lipid product, which can be rehydrated to form the complex
05/29/2003US20030099696 Peptides-containing liposomal surfactants
05/29/2003US20030099685 Implant comprising a material suitable for use in vivo within a subject in combination with osteopontin; enhanced rate of osseointegration and/or augmented percentage of bone apposition around implants
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099670 Comprises RNA-sequence encoding modified RNA-polymerase due to wild-type point mutations apy; genetic engineering; immunotherapy
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099664 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
05/29/2003US20030099663 Also comprises neuroactive compounds, hormones, compounds having growth hormone acitivity, and polypeptide; vaccines
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099653 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/29/2003US20030099650 Treatment of immune disorders and B cell disorders
05/29/2003US20030099649 Composition and method for treating inflammatory disorders
05/29/2003US20030099646 For interfering with cyclin expression or phosphorylation via map-kinase; hybridomas; antitumor agents; antiproliferative agents
05/29/2003US20030099644 CD40 ligand and CD40 agonist compositions and methods of use
05/29/2003US20030099643 Methods for selectively stimulating proliferation of t cells
05/29/2003US20030099642 Inhibiting activation by CD40 ligand (CD40L) of cells bearing CD40 on the cell surface, other than B cells, by contacting with an agent that inhibits the interaction between CD40L and the cells; treating autoimmune diseases, for example
05/29/2003US20030099639 Use in diagnosis; immunoassay
05/29/2003US20030099634 Cytotoxic T lymphocyte (CTL); two peptide epitopes, one binds to an HLA class I molecule and the other to an HLA class II molecule such that they are recognized by a cytotoxic T cell and a human helper T cell; adjuvant, and carrier
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot
05/29/2003US20030099617 Method for using thymosin beta-10 for gene therapy of solid malignant tumors
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/29/2003US20030099612 Genetic engineered human light chain polypeptide for treating disorders associated with cell proliferation; using agonists, antagonists, polynucleotide, or antibodies; specific binding
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099610 Novel uses of avian interferon gamma (ifn-y)
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/29/2003US20030099607 Ifn-y production inducing protein (igif, il-18)
05/28/2003EP1314785A1 Nucleic acids and proteins showing increased expression dose under salt stress
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314780A1 Collagen-binding hybrid polypeptide
05/28/2003EP1314739A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
05/28/2003EP1314738A1 Pseudovirons comprising virus capsids, histones and nucleic acids as therapeutic agents
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1314352A1 Transgenic mammals
05/28/2003EP1314037A2 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313871A1 NUCLEOTIDE SEQUENCES WHICH CODE FOR THE metY GENE
05/28/2003EP1313867A2 Stress-regulated genes of plants, transgenic plants containing same, and methods of use
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313856A1 Citb gene from corynebacteria and use thereof in snythesis of l-amino acids
05/28/2003EP1313855A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313852A2 Dna binding peptide domains and a method for providing domains of this type
05/28/2003EP1313850A2 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
05/28/2003EP1313849A2 Cloned cells, embryos, and avians and methods of producing them
05/28/2003EP1313848A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
05/28/2003EP1313767A2 Peptide with effects on cerebral health
05/28/2003EP1313766A2 Coaster, a human coactivator of steroid receptors
05/28/2003EP1313765A2 Secreted proteins and methods of using same
05/28/2003EP1313764A1 Crystal structure of a ras-pi3k complex
05/28/2003EP1313763A2 Method for the extraction and the use of antibiotically effective peptides for treating infectious diseases
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313761A1 18 human secreted proteins
05/28/2003EP1313760A2 Nucleotide sequences which code for the cita gene
05/28/2003EP1313759A1 Nucleotide sequences which code for the ccpa2 gene
05/28/2003EP1313758A1 Nucleotide sequences which code for the oxyr gene
05/28/2003EP1313757A2 Nucleotide sequences which code for the metr and metz genes
05/28/2003EP1313756A1 Antibodies specific for methylated lysines in histones
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
1 ... 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 ... 2916